Safety, activity and estrogen inhibition by exemestane in postmenopausal women with advanced breast cancer: a phase I study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety, activity and estrogen inhibition by exemestane in postmenopausal women with advanced breast cancer: a phase I study

Published:1998-09 Issue:8 Volume:9 Page:675-683
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:Anti-Cancer Drugs

Author:

Paridaens R,Thomas J,Wildiers J,Vermeiren P,Lobelle J-P,di Salle E,Ornati G,Zurlo MG,Polli A,Lanzalone S,de Belder K

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of the relationship between pharmacokinetics and pharmacodynamics in drug development and therapeutic equivalence: a PEARRL review;Journal of Pharmacy and Pharmacology;2019-02-22

2. Assessment of bone metabolism and biomechanical properties of the femur, following treatment with anastrozole and letrozole in an experimental model of menopause;Oncology Letters;2017-07-18

3. Clinical utility of exemestane in the treatment of breast cancer ;International Journal of Women's Health;2015-05

4. Aromatase inhibitors in the breast cancer clinic: focus on exemestane;Endocrine-Related Cancer;2014-02

5. A Polymorphism at the 3'-UTR Region of the Aromatase Gene Is Associated with the Efficacy of the Aromatase Inhibitor, Anastrozole, in Metastatic Breast Carcinoma;International Journal of Molecular Sciences;2013-09-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP